These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25486947)

  • 1. Infection control practices in patients with hematological malignancies and multidrug-resistant organisms: special considerations and challenges.
    Ariza-Heredia EJ; Chemaly RF
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S104-10. PubMed ID: 25486947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of nosocomial infections and surveillance of emerging resistances in NICU.
    Cipolla D; Giuffrè M; Mammina C; Corsello G
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():23-6. PubMed ID: 21942585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiologic consequences of new approaches to managing hematologic malignancies.
    Blijlevens NM; Donnelly JP; de Pauw BE
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E2. PubMed ID: 16864116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.
    Gedik H; Yıldırmak T; Simşek F; Kantürk A; Arıca D; Aydın D; Yokuş O; Demirel N; Arabacı C
    J Infect Dev Ctries; 2014 Sep; 8(9):1113-8. PubMed ID: 25212075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic stewardship and horizontal infection control are more effective than screening, isolation and eradication.
    Lemmen SW; Lewalter K
    Infection; 2018 Oct; 46(5):581-590. PubMed ID: 29796739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Late infectious complications after high-dose therapy and autologous blood stem cell transplantation].
    Metzner B; Grüneisl R; Gebauer W; Reschke D; Ost E; Müller TH; Reichert D; Rosien B; Del Valle F; Zirpel I; Kohse KP; Schunter F; Illiger HJ
    Med Klin (Munich); 2002 Nov; 97(11):650-8. PubMed ID: 12434273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinations in patients with hematological malignancies.
    Tsigrelis C; Ljungman P
    Blood Rev; 2016 Mar; 30(2):139-47. PubMed ID: 26602587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology and drug resistance of the pathogenic microbes in the complicated infection of hematological malignancies].
    Shen Y; Shen J; Chen Y; Zeng XY; Li JM; Ni YX; Shen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):328-32. PubMed ID: 15308008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low infectious morbidity in patients with heavily pretreated hematological malignancies receiving autologous peripheral blood stem cell transplantation without antimicrobial prophylaxis.
    Yeh SP; Chiu CF; Lo WJ; Lin CL; Hsueh CT; Liao YM; Shen YC
    Ann Hematol; 2003 Jan; 82(1):24-9. PubMed ID: 12574960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which strategies follow from the surveillance of multidrug-resistant bacteria to strengthen the control of their spread? A French experience.
    Lepelletier D; Perron S; Huguenin H; Picard M; Bemer P; Caillon J; Juvin ME; Drugeon HB
    Infect Control Hosp Epidemiol; 2004 Feb; 25(2):162-4. PubMed ID: 14994943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations.
    Santos RP; Mayo TW; Siegel JD
    Clin Infect Dis; 2008 Jul; 47(1):110-6. PubMed ID: 18491966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative management of multidrug-resistant organisms in health care settings.
    Grota PG
    AORN J; 2007 Sep; 86(3):361-8; quiz 369-72. PubMed ID: 17822641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit.
    Maragakis LL
    Crit Care Med; 2010 Aug; 38(8 Suppl):S345-51. PubMed ID: 20647792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of infections of patient with hematological malignancy].
    Sasada M
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():445-9. PubMed ID: 17474445
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
    Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
    Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of changing pathogens of serious infections in hospitalized patients.
    McGowan JE
    Clin Infect Dis; 2000 Sep; 31 Suppl 4():S124-30. PubMed ID: 11017861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in the management of invasive fungal infections in patients with hematological malignancies.
    Karthaus M; Cornely OA
    Ann Hematol; 2005 Apr; 84(4):207-16. PubMed ID: 15614521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infection prevention strategy for antimicrobial-resistant organisms].
    Ohmagari N
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):162-4. PubMed ID: 22333625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program.
    Lavergne V; Ghannoum M; Weiss K; Roy J; Béliveau C
    Bone Marrow Transplant; 2011 Jan; 46(1):137-42. PubMed ID: 20383207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms.
    Bearman GM; Marra AR; Sessler CN; Smith WR; Rosato A; Laplante JK; Wenzel RP; Edmond MB
    Am J Infect Control; 2007 Dec; 35(10):650-5. PubMed ID: 18063129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.